Fundraising FoxStataDx
Boston, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into StataDx
Sign up to see every warm intro you have to StataDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the StataDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
StataDx is developing a point-of-care diagnostic platform for neurology that measures multiple blood biomarkers (such as Neurofilament-light, pTau-217, GFAP, S100b, and UCH-L1) from a fingerprick whole blood sample. The system uses multiplexed cartridges with mobile and cloud connectivity for biomarker-guided disease management in clinics or at patients' homes.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 3 rounds · 2022–2026
▶$1.9MraisedApr 2026 · 7 investors · Other Health CareRule 506(b)
- Daniel LookadooExecutive Officer
- Donald IngberDirector
- Amarpreet SawhneyDirector
- Sidhant JenaExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- Proceeds to insiders
- $175K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedMar 2024 · 5 investors · Other Health CareRule 506(b)
- Donald IngberDirector
- Amarpreet SawhneyDirector
- Sidhant JenaExecutive Officer, Director
- Michal DepaExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.8M
- Proceeds to insiders
- $200K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.7MraisedFeb 2022 · 5 investors · OtherRule 506(b)
- Sidhant JenaExecutive Officer
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- Minimum investment
- $100K
- Proceeds to insiders
- $400K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through StataDx went on to found or lead other companies.
Frequently asked questions
- What does StataDx do?
- StataDx is developing a point-of-care diagnostic platform for neurology that measures multiple blood biomarkers (such as Neurofilament-light, pTau-217, GFAP, S100b, and UCH-L1) from a fingerprick whole blood sample. The system uses multiplexed cartridges with mobile and cloud connectivity for biomarker-guided disease management in clinics or at patients' homes.
- Who are StataDx's investors?
- StataDx's investors include MassVentures.
- How much funding has StataDx raised?
- StataDx has disclosed $6.4M raised across 3 rounds.
- Where is StataDx headquartered?
- StataDx is headquartered in Boston, US.